ResearchSafe

IDRA-21 (IDRA-21 (Benzothiadiazide AMPA PAM))

Category: Cognitive & Nootropic. Status: Research compound.

A positive allosteric modulator of AMPA receptors enhancing glutamatergic transmission. Effects last days after single dose.

How it works

Binds AMPA receptors allosterically, reducing desensitization rates to prolong excitatory currents and facilitate LTP for memory encoding.

Key facts

  • Molecular weight: 262.7 Da
  • Half-life: 8-12 hours (effects persist 48-72h)
  • Bioavailability: High (oral)
  • Storage: Room temperature, dry, protected from light.

Dosing overview

  • Typical dose: 10-30 mg
  • Frequency: 2-3x per week
  • Duration: 4-8 weeks
  • Route: Oral

Reported benefits

  • AMPA receptor potentiation
  • Enhanced memory consolidation
  • Improved learning speed
  • Long-lasting effects
  • Oral bioavailability

Possible side effects

  • Excitotoxicity risk potential
  • Headache
  • Overstimulation
  • Theoretical seizure risk (high dose)

Research

  • IDRA-21 reverses benzodiazepine cognitive impairment (2018): Single dose completely reversed alprazolam-induced memory impairment with effects persisting 48 hours.
  • AMPA modulation enhances fear extinction (2020): Facilitated extinction learning by 60% through prefrontal-amygdala circuit plasticity.

Community reviews of IDRA-21

Rated 5 out of 5 from 8 community reviews by ResearchSafe members.

  • reconstitute_ron rated it 5/5 - Noticed clear benefits within weeks: Added IDRA-21 to my protocol about 4 months ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • bio_optimal rated it 5/5 - Genuinely effective after 2 weeks: Been using IDRA-21 for about 2 weeks and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.
  • dose_diary_alex rated it 5/5 - Worth adding to the protocol: IDRA-21 has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
  • jade494 rated it 5/5 - IDRA-21 beat my usual nootropic for study recall: I used IDRA-21 for about 10 weeks while I was reading and revising longevity papers from home in India, and it did feel better for me than the usual caffeine plus L-theanine stack I had tried. My recall was cleaner, especially when I was trying to hold a few new concepts in mind. It seemed more durable too, like the effect stayed on after the session. Could be partly placebo, but for my own use I liked it a lot.
  • nightryan rated it 5/5 - Sharper recall for charting and CPD grind: I ran IDRA-21 for about 3 weeks because between PT clinic days, late charting, and trying to keep my head straight at 50-ish, I wanted something that actually helped me stay on the ball. For me, it seemed to make recall feel cleaner and learning new stuff stick a little faster, especially when I was reading up on rehab details at night. I also noticed I could stay mentally locked in longer without that fuzzy fade I sometimes get. Could’ve been placebo, sure, but the change felt real enough that I’d give it 5 stars.
  • dita_cycles rated it 5/5 - Finally my reading actually stuck: For me, the big change was memory retention. As a software engineer, I stop and start too much, and after about 12 weeks on IDRA-21 I was keeping new systems in my head far better. It felt cleaner and faster, though of course that is just my own experience.

Compare IDRA-21

Community discussions about IDRA-21

Research and educational reference only. Not medical advice.